How to Import Medical Devices Without Local Entity: The Complete IOR Guide for 8 Key Markets

Every organisation expanding its global medtech footprint faces the same question: can we import medical devices without local entity registration in every destination market? The answer in most markets is yes, provided you appoint a specialist Importer of Record with established regulatory standing in each destination country. Medical devices carry a compliance burden that standard commercial goods do not. In addition to customs classification, duties, and import documentation, each destination market requires pre-market regulatory approval, device registration with the local health authority, and in most cases a locally registered entity to hold that registration on behalf of a foreign manufacturer. That entity does not have to be your company. When you import medical devices without local entity registration of your own, a specialist IOR provider holds the required local credentials, manages the health authority relationship, coordinates the device registration, and files the customs declaration on your behalf. This guide covers eight key markets, explains what the classification-based differences mean, what the 2026 regulatory changes require, and what the four most common mistakes are that delay medical device market entry by months.

Four Mistakes That Delay Medical Device Market Entry by Months

These mistakes are presented first because they are the errors that cause the most damage and that experienced supply chain directors and regulatory affairs managers see most often. Fix these before anything else.

Mistake 1: Assuming CE marking opens all markets. CE marking under EU MDR demonstrates compliance with EU requirements only. It does not provide market access in the US, UK, Australia, Japan, Brazil, India, or Saudi Arabia. Each of those markets has its own regulatory pathway and its own approval process that must be completed independently. A device CE-marked for the EU that is shipped to Brazil without ANVISA registration will be refused entry regardless of its EU compliance status. Companies planning to import medical devices without local entity across multiple markets must confirm the specific approval requirements in each market separately.

Mistake 2: Booking freight before confirming registration status. Medical device registration processes take months in most regulated markets. A company that books ocean freight before confirming ARTG listing in Australia, ANVISA registration in Brazil, or SFDA registration in Saudi Arabia will have goods sitting at the destination port accumulating demurrage while the registration process completes. When you import medical devices without local entity across new markets, the registration timeline is the critical path. It must be the first item on the market entry project plan, not an afterthought after the supplier order is placed.

Mistake 3: Appointing a regulatory consultant without also appointing an IOR. The Authorised Representative in the EU, the Australian Sponsor, the Japanese DMAH, and the Brazilian Detentor de Registro are regulatory roles that manage the health authority relationship and hold device approvals. These are distinct from the IOR role that files the customs declaration and manages the physical import. Both roles are required. A regulatory consultant who does not also act as IOR leaves a gap between the two functions that produces clearance delays. A specialist provider who fulfils both roles simultaneously closes that gap. See the full breakdown: Freight Forwarder vs Importer of Record.

Mistake 4: Underestimating cold chain and batch tracking requirements. Diagnostic analysers, reagent kits, calibration standards, and biological reference materials have temperature control requirements from the manufacturer’s facility to the hospital or clinic receiving them. Serial number and batch tracking for medical devices subject to post-market surveillance obligations is mandatory in most regulated markets. Standard freight forwarding without cold chain capability and batch tracking documentation is not appropriate for regulated medical products. Confirm these requirements with your IOR provider before the first shipment, not after.

Import Medical Devices Without Local Entity: Eight Markets Explained

United States

• Regulator: FDA Center for Devices and Radiological Health (CDRH)
• Classification: Class I (exempt or general controls), Class II (510(k) clearance required), Class III (Premarket Approval required)
• Local entity required: No US entity required, but a US Agent must be designated by every foreign manufacturer. The US Agent is physically located in the United States and acts as FDA’s contact for the manufacturer
• Pre-market requirements: FDA Establishment Registration annually. Device Listing. 510(k) clearance or PMA approval for Class II and III. FDA ACE entry data requirements include the Device Listing Number, Establishment Registration Number, and applicable clearance or approval number on every customs entry filing. This is separate from and must not be confused with FDA Prior Notice, which applies to food and beverages only. Full requirements published on the FDA official medical device guidance page
• IOR solution: A specialist IOR with FDA Establishment Registration capability, US Agent coordination, and ACE filing authority for FDA-regulated device entries handles the complete US import function without the manufacturer needing a US entity

For IOR in the USA, confirm that your IOR provider holds active FDA Establishment Registration and can coordinate US Agent designation for your manufacturing establishment.

European Union: Critical 2026 Update

EUDAMED Registration: Critical May 28, 2026 Deadline. On May 28, 2026, the first four modules of EUDAMED, the European Database on Medical Devices, became mandatory for all devices placed on the EU market. These modules are: Actor Registration, UDI (Unique Device Identification), Notified Body and Certificate Management, and Market Surveillance. Every non-EU manufacturer must have a Single Registration Number (SRN) issued through EUDAMED before their EU Authorised Representative can complete device registration. Without a valid SRN, devices cannot be legally imported into the EU market. If your EU Authorised Representative has not completed EUDAMED Actor Registration and obtained your SRN before shipping, your goods will be non-compliant from the point of import.

• Regulator: EU Notified Body plus national competent authority (e.g. BfArM in Germany, ANSM in France)
• Classification: Class I, IIa, IIb, III under MDR 2017/745. Class A, B, C, D under IVDR 2017/746 for diagnostics
• Local entity required: EU Authorised Representative mandatory for all non-EU manufacturers under MDR Article 11. The AR holds the SRN in EUDAMED and is the EU regulatory contact
• Pre-market requirements: CE marking. Notified Body assessment for Class IIa and above. EUDAMED SRN and device registration. CE marking is the legal route to EU market access for medical devices
• Importer obligations: Under MDR Article 13, the importer must verify CE marking is correctly applied, confirm the AR is appointed, ensure labelling is in the destination member state language, and confirm storage and transport conditions
• IOR solution: A specialist provider holding EORI, VAT registration, MDR Article 13 importer status, and EU Authorised Representative credentials manages both the regulatory and physical import functions simultaneously

For Germany, France, Netherlands, and all EU markets, confirm your AR has completed EUDAMED registration and obtained your SRN before any shipment to EU customers.

United Kingdom

• Regulator: MHRA (Medicines and Healthcare products Regulatory Agency)
• Classification: Class I, IIa, IIb, III under UK Medical Devices Regulations 2002
• Local entity required: UK Responsible Person mandatory for all non-UK manufacturers. The UK Responsible Person is legally established in Great Britain and performs the equivalent function to the EU Authorised Representative
• CE marking in 2026: The UK government has extended recognition of CE-marked devices. Class I devices retain CE mark recognition until June 30, 2028. Class IIa, IIb, and Class III devices and active implantable devices retain CE mark recognition until June 30, 2030. In early 2026, the MHRA launched a formal consultation on potentially recognising EU MDR and IVDR CE-marked devices on an indefinite basis. Do not state that the CE mark transition period has concluded. It has not, and UKCA marking is not yet the sole route to UK market access for higher-risk devices
• IOR solution: A specialist UK IOR holds EORI, VAT registration, and UK Responsible Person credentials, managing both regulatory and import compliance functions

For IOR in the UK, confirm that your UK Responsible Person is appointed and MHRA registration is current before shipping to UK customers.

Australia

• Regulator: TGA (Therapeutic Goods Administration)
• Classification: Class I, IIa, IIb, III, AIMD under Therapeutic Goods Act 1989
• Local entity required: Australian Sponsor mandatory. The Sponsor holds the ARTG (Australian Register of Therapeutic Goods) listing on behalf of the foreign manufacturer. A foreign manufacturer cannot hold ARTG listing directly without an Australian entity
• Pre-market requirements: ARTG listing must be confirmed before any commercial import. Typical timeline: 3-6 months for listed devices
• IOR solution: A specialist IOR acting as Australian Sponsor holds the ARTG listing, manages TGA obligations, and handles import clearance and customs duties on behalf of the foreign manufacturer

For IOR in Australia, the Sponsor and IOR functions are combined in a single locally registered provider, eliminating the coordination gap between regulatory and customs roles.

Japan

• Regulator: PMDA (Pharmaceuticals and Medical Devices Agency) and MHLW (Ministry of Health, Labour and Welfare)
• Local entity required: DMAH (Designated Marketing Authorisation Holder) mandatory. The DMAH is a Japanese-registered entity that holds the MHLW marketing authorisation (shounin) and bears full regulatory responsibility
• Pre-market requirements: MHLW shounin required for Class II, III, and IV devices. Timeline for Class III: 12-24 months. A foreign manufacturer cannot obtain MHLW approval without appointing a DMAH
• IOR solution: Carra Globe’s local entity holds DMAH credentials and acts as the legal importer of record. You do not need to incorporate in Japan. The DMAH appointment must precede any shipment

For IOR in Japan, Japan is one of the longest regulatory timelines in the world. Begin PMDA submission and DMAH appointment at the earliest possible stage of market entry planning.

Brazil

• Regulator: ANVISA (Agencia Nacional de Vigilancia Sanitaria)
• Local entity required: Brazilian Detentor de Registro mandatory. Must be a Brazilian-registered company holding CNPJ, RADAR authorisation, and ANVISA registration
• Pre-market requirements: ANVISA registration required for Class II, III, and IV devices before commercial import. Class III registration: 12-18 months typical timeline. This is the longest registration timeline in the guide
• IOR solution: The Detentor de Registro also serves as the commercial IOR for customs, holding CNPJ, RADAR, and SISCOMEX filing capability in a single provider

For IOR in Brazil, start ANVISA registration the day you decide to enter the Brazilian market. Do not wait until product development is complete.

India

• Regulator: CDSCO (Central Drugs Standard Control Organisation)
• Local entity required: Indian IOR holding CDSCO import licence under Medical Devices Rules 2017, active IEC (Import Export Code), and GST registration
• Pre-market requirements: CDSCO import licence required. Classification: Class A, B, C, D. BIS CRS certification applies to certain electronic medical devices
• IOR solution: A third-party IOR with established Indian entity, active IEC, and CDSCO import licence for the relevant device categories manages the complete import function

For IOR in India, confirm CDSCO and BIS classification for your specific device before engaging an IOR, as licensing process varies significantly by device risk class.

Saudi Arabia

• Regulator: SFDA (Saudi Food and Drug Authority)
• Local entity required: Saudi establishment holder to hold SFDA registration. Must be Saudi-registered
• Pre-market requirements: SFDA registration required before import. Class B (medium risk): 6-12 months. This timeline regularly catches medical device importers planning hospital and data centre deployments off-guard
• IOR solution: Specialist IOR with Saudi establishment credentials manages SFDA registration coordination and customs import function simultaneously

For IOR in Saudi Arabia, SFDA registration must begin at least six months before planned first shipment for Class B devices. For Class C and D devices, allow longer.

Classification and IOR Coverage: Eight Markets at a Glance

How to Import Medical Devices Without Local Entity in Four Steps

1. Step 1: Confirm device classification in every target market. The same device may carry different risk classifications in different markets. Each classification level determines the pre-market approval process, the Notified Body or health authority review required, and the documentation the IOR must have before legal import is possible. A Class II device in the US may be Class IIb in the EU or Class III in Brazil. Confirm classification in every target market before committing to any delivery timelines. When you import medical devices without local entity across multiple countries, classification mismatches between markets are the most common source of unexpected regulatory delays
2. Step 2: Start regulatory registration immediately. Registration timelines are the critical path. Brazil ANVISA for Class III: 12-18 months. Japan PMDA for Class III: 12-24 months. Saudi Arabia SFDA for Class B: 6-12 months. Australia TGA for listed devices: 3-6 months. EU Notified Body for Class IIb: 6-12 months. US FDA 510(k): 6-12 months. Begin registration in every target market in parallel with supply chain preparation. Every day of registration delay is a day of revenue delay
3. Do not book freight until your local representative is legally appointed. The EU Authorised Representative must have your EUDAMED SRN confirmed before any EU shipment. The Australian Sponsor must hold your ARTG listing. The Japanese DMAH must have your MHLW approval. The Brazilian Detentor de Registro must hold your ANVISA registration. Carra Globe provides this exact legal infrastructure in all eight markets covered in this guide. Do not book freight with any carrier until we have confirmed that all regulatory appointments and approvals are in place for your specific device in your specific destination market. Our IOR services for medical devices include pre-shipment regulatory review and the legal local representative function in every market
4. Confirm cold chain, serial tracking, and batch documentation for your device. Diagnostic instruments, reagent kits, and sterile devices have specific handling requirements. Confirm with your IOR provider before the first shipment that storage, temperature monitoring, and batch tracking are fully established in the destination country. Our Freight Forwarding service manages temperature-controlled logistics and serial number tracking as part of the standard medical device import service

How Carra Globe Supports Medical Device Imports Across 175+ Countries

Carra Globe provides IOR services for medical devices, diagnostic equipment, and laboratory instruments across 175+ countries. Our pre-shipment regulatory review confirms device registration status, required approvals, and correct classification in the destination market before any freight is booked. Understanding what an Importer of Record does for medical devices means recognising that the IOR role combines regulatory standing, local representative credentials, and customs filing capability in a single provider. For foreign manufacturers who need to import medical devices without local entity registration, our locally registered entities hold the customs registration, import licences, local representative credentials, and health authority relationships required for compliant medical device imports in each market. Our Delivered Duty Paid service incorporates all duty, import licence, and customs clearance costs into a single guaranteed landed cost before any procurement commitment is made. Our Freight Forwarding service manages temperature-controlled logistics, cold chain documentation, and serial number tracking for medical devices from origin to hospital, clinic, or research facility. For market-specific regulatory context, see our country guides for USA, Germany, Australia, Japan, Brazil, India, and Saudi Arabia.

Frequently Asked Questions

Can a foreign manufacturer import medical devices without local entity?

Yes, through a specialist third-party IOR. Every market in this guide requires a locally registered entity to hold the device registration, import licence, local representative role, or all three. That entity does not have to be the manufacturer’s own subsidiary. A specialist IOR provider with established local credentials and health authority registrations can import on behalf of a foreign manufacturer in all eight markets covered here without the manufacturer incorporating a local company in any of them.

What changed in the EU for medical device imports in May 2026?

On May 28, 2026, four EUDAMED modules became mandatory for all medical devices placed on the EU market: Actor Registration, UDI, Notified Body and Certificate Management, and Market Surveillance. Every non-EU manufacturer must have an SRN (Single Registration Number) issued through EUDAMED before their EU Authorised Representative can complete device registration. Without a valid SRN, devices imported into the EU market after May 28, 2026 are non-compliant. If your EU AR has not completed EUDAMED Actor Registration and obtained your SRN, resolve this immediately before the next EU shipment.

Is CE marking still valid in the UK in 2026?

Yes. CE-marked devices continue to be accepted in Great Britain (England, Scotland, Wales) under extended transitional arrangements. Class I CE-marked devices are recognised until June 30, 2028. Class IIa, IIb, Class III devices and active implantable devices are recognised until June 30, 2030. In early 2026 the MHRA launched a consultation on potentially recognising EU MDR and IVDR CE-marked devices on an indefinite basis. A UK Responsible Person must still be appointed and MHRA registration must be current regardless of whether the device carries CE or UKCA marking.

How long does it take to import medical devices without local entity in Brazil and Japan?

Brazil ANVISA registration for Class III devices typically takes twelve to eighteen months. Japan PMDA approval for Class III devices takes twelve to twenty-four months. Both are among the longest regulatory timelines in the world for medical device market entry. These timelines are the critical path for Brazil and Japan. Begin ANVISA and PMDA registration at the earliest possible stage of the market entry project. Do not wait until supply chain preparation is complete before starting regulatory processes in these markets.

What is the difference between the EU Authorised Representative and the IOR?

The EU Authorised Representative is a regulatory role under MDR Article 11: it registers the device in EUDAMED, obtains the SRN, and is the EU regulatory contact for the manufacturer. The IOR is the customs and trade role under MDR Article 13: it files the EU import declaration, pays duties and VAT, and bears importer obligations. Both are required for non-EU manufacturers importing into the EU. A specialist provider who holds both roles simultaneously eliminates the coordination risk between the two functions and ensures no compliance gap exists between regulatory approval and physical import.